Lam Research reported $23.2B of revenue over the trailing twelve months, +26% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $23.2B (to Q4 2026). Net income: $7.27B, trailing twelve months to Q4 2026. Free cash flow: $4.89B, trailing twelve months to Q4 2026. Operating margin: 35%, trailing twelve months to Q4 2026.

LRCXLam Research

Technology

$318.81+154% 1Y

$318.81

$126.2252 weeks$409.54

LRCX as reported

Lam Research reported $23.2B of revenue over the trailing twelve months, +26% on the year before. 11 reported series are charted on this page, each one as filed.

$23.2B

Revenue, trailing twelve months · to Q4 2026 · +26% against the twelve months before

Net income: $7.27B
Net income · +36% year on year · trailing twelve months to Q4 2026
Free cash flow: $4.89B
Free cash flow · −9.7% year on year · trailing twelve months to Q4 2026
Operating margin: 35%
Operating margin · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for LRCX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$23.2B	+26%	Q4 2026
Net income	$7.27B	+36%	Q4 2026
EPS	$5.76	+39%	Q4 2026
Gross margin	50%	n/a	Q4 2026
Operating margin	35%	n/a	Q4 2026
Net margin	31%	n/a	Q4 2026
ROE	60%	n/a	Q4 2026
ROA	30%	n/a	Q4 2026
ROIC	63%	n/a	Q4 2026
Free cash flow	$4.89B	−9.7%	Q4 2026
P/E	55.4	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.